Beeline Medicines
The Director, CMC Product Development – Small Molecule is a senior technical and operational leader responsible for the end-to-end CMC development of small molecule drug product candidates, from early formulation through process development, clinical supplies, and regulatory submission. This role drives drug product development activities on assigned programs, working cross-functionally with internal teams and external CDMO partners to ensure scientific rigor and operational excellence. The position requires deep expertise in small molecule formulation science and manufacturing, with a focus on taking programs through late-stage development and filing.
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies that target the drivers of immune dysfunction. The company is advancing a pipeline of therapies for autoimmune and inflammatory diseases, including its lead program afimetoran, a TLR7/8 inhibitor in late-stage clinical development for lupus. Beeline Medicines aims to define new treatment paradigms for patients living with chronic immune-mediated conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beeline Medicines.
Director, CMC – Small Molecule Chemistry
Pathos
Director, Drug Product SME
Madrigal Pharmaceuticals
Associate Director, Technical Operations (Small Molecule CMC)
Travere Therapeutics
Lead and mentor the Oligonucleotide & Small Molecule CMC Analytical Development team
Denali Therapeutics
Associate Director Drug Product SME
Madrigal Pharmaceuticals
CMC Professional
Crescent Biopharma